Moderna, Inc. MRNA
NASDAQ · United States · Health Technology
$192.57-10.89 (-5.35%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The publisher cites Marvell’s growth and Yum’s margins, while pointing to declining sales and profitability at Moderna.
The Florida Republican disclosed a cluster of August trades spanning SpaceX, Berkshire Hathaway, biotech and technology stocks.